MRS. STEPHANIE TORRES-ACUNA RN NPI 1851877534

NPI Details

MRS. Stephanie Torres-acuna, RN is a family nurse practitioner in St. Thomas, VI with 4 years of experience. MRS. Stephanie Torres-acuna, RN NPI is 1851877534. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

9053 ESTATE THOMAS
SUITE 106
ST. THOMAS, VI
ZIP 00802-613
Phone: (340) 777-6423
Fax: (800) 980-8620

The NPI 1851877534 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)

The enumeration date for this NPI number is 7/16/2018 and was last updated on 7/2/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: